首页>
外国专利>
METHOD FOR ASSESSING THE RISK OF CUTANEOUS ADVERSE DRUG REACTIONS INDUCED BY ANTI-EPILEPTIC DRUG LAMOTRIGINE, DETECTION REAGENT THEREOF AND USE THEREOF
METHOD FOR ASSESSING THE RISK OF CUTANEOUS ADVERSE DRUG REACTIONS INDUCED BY ANTI-EPILEPTIC DRUG LAMOTRIGINE, DETECTION REAGENT THEREOF AND USE THEREOF
展开▼
机译:评估抗癫痫药物拉莫三嗪引起的反复不良药物反应的风险的方法,检测试剂的用途和使用方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for assessing the risk of cutaneous adverse drug reactions induced by an anti-epileptic drug Lamotrigine is provided, wherein the cutaneous adverse drug reactions include but are not limited to: maculopapular eruption (MPE), fixed drug eruption (FDE), Stevens Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and systemic symptoms (DRESS). Further provided is a detection reagent for assessing the risk of a patient developing the cutaneous adverse drug reactions induced by the anti-epileptic drug Lamotrigine, comprising agents for measuring a particular HLA allele and the use thereof.
展开▼